Sign In
18 May 2012 12:02
ο»Ώ
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | |||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||||||||
Β An acquisition or disposal of voting rights | Β β | |||||||||
Β An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||||||||
Β An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||||||||
Β An event changing the breakdown of voting rights | ||||||||||
Β Other (please specify): |
| |||||||||
3. Full name of person(s) subject to the notification obligation: Β | 1Lansdowne Partners Limited being the General Partner of Lansdowne Partners Limited Partnership Β 2Lansdowne Partners International Limited | |||||||||
4. Full name of shareholder(s) (if different from 3.): Β | Β HSBC Client Holdings UK Ltd Β (Registered Shareholder) | |||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: Β | Β 15/5/12 | |||||||||
6. Date on which issuer notified: Β | Β 17/5/12 | |||||||||
7. Threshold(s) that is/are crossed or reached: Β | Β 5% | |||||||||
8. Notified details: | ||||||||||
A: Voting rights attached to shares Β | ||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||
Β Ordinary Shares | 11,748,373 | 11,748,373 | Below 5% | Below 5% | ||||||
Β GB0034251727 | ||||||||||
Β
B: Qualifying Financial Instruments | |||||||||
Resulting situation after the triggering transaction Β | |||||||||
Type of financialinstrument | Expirationdate | Exercise/ConversionPeriod | Number of votingrights that may beacquired if theinstrument isexercised/ converted. Β | % of votingrights | |||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||
Resulting situation after the triggering transaction Β | |||||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights Β | ||||
Nominal | Delta Β | ||||||||
Total (A+B+C) Β | |||||||||
Number of voting rights | Percentage of voting rights | ||||||||
Β Below 5% | Β Below 5% | ||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | |||||||||
Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited | |||||||||
Proxy Voting: Β | |||||||||
10. Name of the proxy holder: Β | Β Lansdowne Partners Limited | ||||||||
11. Number of voting rights proxy holder will cease to hold: Β | |||||||||
12. Date on which proxy holder will cease to hold voting rights: Β | |||||||||
Β
13. Additional information: Β | |
14. Contact name: Β | Β Kamran Salahuddin |
15. Contact telephone number: Β | Β +44 20 7290 5500 |
Β
Follow the stocks
